Published : 18 Jun 2026
CHICAGO, IL — June 18, 2026 — Aagami, Inc. has received a new strategic assignment from a highly valued existing client. Under this expanded mandate, Aagami will lead the effort to identify, negotiate, and secure exclusive regional partners for the client's cutting-edge technologies in Japan and South Korea.
The client, an innovative California-based medical technology company, is pioneering the future of healthcare by integrating advanced imaging, artificial intelligence (AI), and robotic guidance.
Target Markets: Identification and securing of premier, exclusive regional partners in Japan and South Korea.
Technology Scope: Commercialization and strategic positioning of the client's state-of-the-art imaging systems, AI-driven diagnostic software, and robotic-assisted intervention platforms.
Deepening Partnership: This assignment marks a significant expansion of an ongoing, highly successful relationship between Aagami and the client.
Having previously collaborated successfully on key strategic initiatives, the client has once again entrusted Aagami with this mandate due to its deep domain expertise, extensive cross-border network, and proven track record of executing high-value licensing and distribution deals in East Asia.
Japan and South Korea represent critical growth regions for advanced medical imaging and robotics, driven by a strong clinical appetite for innovative healthcare solutions. Aagami will leverage its specialized network to connect the client with top-tier medical device distributors and strategic partners capable of maximizing market penetration.
To know more, please contact us on action@aagami.com
The client is a California-based medical technology company developing and commercializing customer-centric imaging, AI, and robotic platforms. They are dedicated to transforming the quality of care by bringing advanced diagnostic and image-guided intervention technologies directly to the forefront of modern medicine.
Aagami is a premier global consulting firm that helps life sciences, biotechnology, and medical device companies achieve global growth. Through strategic partnering, technology licensing, and cross-border joint ventures, Aagami bridges the gap between innovative Western technologies and high-growth international healthcare markets.